168 related articles for article (PubMed ID: 15338199)
1. Is the antiplatelet effect of aspirin affected by systemic inflammation?
Poulsen TS; Mickley H
Ann Hematol; 2004 Nov; 83(11):728. PubMed ID: 15338199
[No Abstract] [Full Text] [Related]
2. Drug insight: aspirin resistance--fact or fashion?
Patrono C; Rocca B
Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
[TBL] [Abstract][Full Text] [Related]
3. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
4. [Aspirin resistance].
Yilmaz MB; Balbay Y; Korkmaz S
Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
6. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
7. Aspirin response variability assessed with the PFA-100 device.
Reny JL; Quéré I; de Moerloose P; Fontana P
Thromb Haemost; 2008 May; 99(5):968-9; author reply 969. PubMed ID: 18449432
[No Abstract] [Full Text] [Related]
8. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
[No Abstract] [Full Text] [Related]
9. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
10. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
Mani H; Lindhoff-Last E
Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
[No Abstract] [Full Text] [Related]
11. Aspirin resistance and atherothrombotic disease.
Maree AO; Jneid H; Fitzgerald DJ
J Am Coll Cardiol; 2006 Aug; 48(4):846-7; author reply 847. PubMed ID: 16904562
[No Abstract] [Full Text] [Related]
12. [Monitoring of antiplatelet drug effects--fashion or necessity?].
Kuliczkowski W; Zembala M; Poloński L; Kaczmarski J; Gasior M
Kardiol Pol; 2008 Jan; 66(1):119-24. PubMed ID: 18266199
[No Abstract] [Full Text] [Related]
13. [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
Bousser MG; Lecrubier C
Nouv Presse Med; 1973 Jun; 2(25):1687-92. PubMed ID: 4718537
[No Abstract] [Full Text] [Related]
14. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
15. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
Bondar' TN; Kravchenko NA
Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
[TBL] [Abstract][Full Text] [Related]
16. [Aspirin resistance theory].
Porosińska A; Pierzchała K
Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
[TBL] [Abstract][Full Text] [Related]
17. Variability of response to antiplatelet therapy: what should we do next?
Shantsila E; Lip GY
Fundam Clin Pharmacol; 2009 Feb; 23(1):19-22. PubMed ID: 19267768
[No Abstract] [Full Text] [Related]
18. Monitoring the antiplatelet action of aspirin.
Fritsma GA; Ens GE; Alvord MA; Carroll AA; Jensen R
JAAPA; 2001 May; 14(5):57-8, 61-2. PubMed ID: 11523339
[No Abstract] [Full Text] [Related]
19. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
20. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
